Speaker illustration

Doctor Louise Ziegler

Karolinska Institute, Stockholm (Sweden)

IL6 trans-signalling is associated with a higher risk of cardiovascular events in individuals with diabetes

Event: ESC Congress 2021 - The Digital Experience

Topic: Biomarkers

Session: Congress committee e-posters choice in preventive cardiology and special populations


IL6 trans-signalling affects risk of cardiovascular events pre-eminently in men

Event: ESC Congress 2019

Topic: Epidemiology

Session: Risk Factors and Prevention, Cardiovascular Disease in Special Populations


The soluble IL6 receptor and ischemic cerebrovascular disease

Event: ESC Congress 2018

Topic: Pathophysiology and Mechanisms

Session: Peripheral vascular and cerebrovascular disease: pathophysiology


The soluble IL6 receptor as a predictor for early cardiovascular events

Event: ESC Congress 2017

Topic: Epidemiology, lipids

Session: Inflammation and cardiovascular disease: the emerging role of 'omics'


Circulating Levels of the Soluble IL6 Receptor and Risk for Future Cardiovascular Events.

Event: ESC Congress 2016

Topic: Inflammation and microcirculation

Session: Registries miscellaneous


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb